Awards

Tavpritesh Sethi of Indraprastha Institute of Information Technology Delhi in India will develop an AI-based platform for AMR surveillance and management across a broad network of public and private hospitals in India. The platform will extract weekly data on AMR from the All India Institute of Medical Sciences, New Delhi (AIIMS Delhi) hospital and the Max Healthcare hospital network, including patterns of antibiotic prescriptions across the network. It will use a federated data analysis approach (joint analysis without sharing the data itself), and they will develop and integrate AI-based models to identify and predict trends in AMR. They will also create applications driven by these models to widely and effectively communicate the analyses to healthcare professionals. This will support antibiotic stewardship and data-driven AMR management at both the local and regional levels.

Sai Raj Reddy of Daia Tech Private Limited in India will develop a program to increase access to health education and related resources for adolescent girls in rural areas of the Indian state of Karnataka. The program will be developed in partnership with the Karnataka Health Promotion Trust, building on their ongoing work with local schools, healthcare providers, community leaders, and government agencies. After engaging community members to understand the local context, they will develop resources for adolescent girls including life skills courses and health education workshops and pilot test the program in selected villages. They will integrate AI tools across the program to broaden participation and to broaden the range of health outcomes improved for adolescent girls.

Bruno Mmbando of Kampala International University in Tanzania will model the combined impact of malaria chemoprevention strategies and vaccines on the burden of childhood malaria in Africa. A modeling focus will be on determining the level of vaccine uptake at which chemoprevention strategies cease to be cost-effective in settings with moderate to high malaria transmission. Data modeling will include the short- and long-term effects of parasite antimalarial drug resistance on the combined impact of chemoprevention and vaccines. The multidisciplinary team will include data modelers, health economists, clinical trialists, and epidemiologists. They will work closely with malaria decision-making organizations, leading to tools and processes that better support the use of malaria data modeling to inform public health interventions.

This grant is funded by The Wellcome Trust.

Belehalli Pavan of Strideaide Private Limited in India will develop an AI-based platform to increase timely access to diagnosis and treatment for diabetic foot ailments. Early detection of peripheral neuropathy, peripheral arterial disease, and diabetic foot ulcers would enable interventions that reduce the need for limb amputation. The platform will build on their existing network of podiatry clinics located in a variety of public spaces. These clinics are staffed with a paramedic providing treatment guided by diagnostic tools including a foot mat with a plantar pressure sensor to help predict and assess foot-bottom ulceration. Existing and new digital data from these clinics will be used to build a diabetic foot registry, to improve automated assessment through AI-based analysis, and to train an LLM with a chatbot interface for clinical decision support across the podiatry clinics.

Amrita Mahale of ARMMAN in India will incorporate an LLM-based chatbot into the Kilkari mobile health service to answer questions about pregnancy and infant care. Kilkari currently provides weekly pre-recorded messages on preventive care, and it is implemented in partnership with India's Ministry of Health and Family Welfare. They will assess different available LLMs and train the best candidate with the Kilkari database of vetted content. They will pilot test the model with Kilkari users through WhatsApp, engaging users in Delhi and in the state of Jharkhand to encompass diverse participants spanning urban, rural, and tribal populations. The test will include regular surveys to measure the service's accuracy, relevance, and usability.

Mohanasankar Sivaprakasam of the Healthcare Technology Innovation Centre at the Indian Institute of Technology Madras in India will develop an AI-based platform to support diagnosis and report generation for endoscopic gastrointestinal exams. They will use curated datasets of annotated endoscopic images to develop an AI-based model for diagnosing gastrointestinal abnormalities, such as polyps and ulcers. The data will also be used to train a Large Language Model (LLM) to generate diagnostic reports of endoscopic exams including representative images and text descriptions. This will improve report quality and consistency for better diagnosis and more accurate, detailed patient records, with the report automation reducing the time and personnel required. Together, these platform components will improve patient care in gastroenterology, including more efficient care across more patients.

Ntombifikile Mtshali of Shout-It-Now with Elona Toska of the University of Cape Town, both in South Africa, will pilot test use of ChatGPT to provide information on sexual and reproductive health that helps young women and adolescent girls in South Africa make informed decisions and effectively access health services. They will test integration of the chatbot into Shout-It-Now's existing platforms: a tablet-based platform in mobile clinics staffed by young women and a mobile phone app. They will train ChatGPT to provide information on sensitive topics, including gender-based violence, HIV infection risk, and pregnancy, using existing materials and guided by a workshop with mobile clinic staff. Users' perception of the chatbot and the chatbot's effectiveness in increasing the use of health services will be assessed using on-line questionnaires and phone surveys across five demographically different districts.

Vijay Sai Trap of OnionDev Technologies Pvt. Ltd. in India will develop an AI-based platform to provide accurate and private automated answers to questions on sexual health and mental well-being for youth and women in rural India. They will generate a dataset of community-generated questions on these topics during a mental health awareness campaign in the Indian states of Uttar Pradesh, Madhya Pradesh, and Tamil Nadu. With the support of subject matter experts, they will add answers to these questions from the relevant literature. They will then create a master dataset of questions and answers, including translations using an existing LLM trained on local Indian languages. This dataset will be used to compare different AI-based models to identify the one best able to effectively answer questions on these sensitive topics.

Himanshu Sinha of the Indian Institute of Technology Madras in India will develop an LLM-based chatbot to provide personalized reliable guidance on antenatal care in multiple Indian languages, particularly for mothers without regular access to health care. The chatbot will use an open-source LLM and will be incorporated into a mobile phone application. The project will begin by surveying pregnant women seeking care in a variety of health care settings and across all three trimesters, asking them what features they would want in a pregnancy app. The LLM will be trained with information from textbooks, clinical manuals, government health resources, and guidelines from professional organizations. Initially the chatbot will function in Hindi and Tamil, with additional Indian languages to follow. The app will track pregnancy milestones and deliver relevant evidence-based advice.

Sean Stowell of Brigham and Women's Hospital in the U.S. will analyze the human antibody repertoires targeting microbes in the female genital track (FGT) to guide the design and use of live biotherapeutic products for bacterial vaginosis. They will use their microarray platform, consisting of an array of antigens from FGT microbes, to analyze genital tract samples from a cohort of women in an HIV drug clinical study in South Africa. They will define the association between FGT antibody levels and specificity with FGT microbial colonization and inflammation. They will also perform experiments to explore potential mechanisms for antibody-mediated microbial attachment and colonization, focusing on antibody interactions with FGT mucin proteins. Together, the results will set the stage for using the microarray platform to identify patient-specific variables as biomarkers to predict the success of live biotherapeutic products.

Saliou Fall of the Institut Senegalais de Recherches Agricoles in Senegal will develop techniques to estimate biological nitrogen fixation (BNF) by legume crops to guide their use as alternatives to nitrogen fertilizers for more sustainable agriculture. They will assess BNF by estimating three underlying components. Crop biomass and the proportion that is nitrogen will be estimated by AI-based models, and the nitrogen fraction that comes from BNF will be estimated by measuring the levels of a stable isotope of nitrogen in the soil and in the plants. As test crops for data to train the AI models, they will grow groundnut and cowpea as staple legumes, with an adjacent non-nitrogen-fixing crop, and crotalaria as a cover crop. They will acquire images of the crops from drones or mobile phone applications, and perform laboratory analyses, including measuring biomass, analysis by near-infrared spectroscopy and wet chemistry, and measuring the natural isotope of nitrogen.

Daniel Kwaro of CREATES in Kenya will develop an early warning system for malaria outbreaks, floods, and heatwaves in Siaya County in Kenya, co-designing it with the local community. They will incorporate health and demographic surveillance system data, including a specific focus on maternal health indicators and birth outcomes, as well as data from automated weather stations, wearable devices, and mosquito traps. Through secondary data analyses, they will assess the probability and consequences of climate-related hazards, including identifying vulnerable communities, high-risk geographical areas, and occurrence patterns of climate-sensitive diseases. They will actively involve Siaya County residents, healthcare providers, and relevant local authorities in co-designing the early warning system paired with multiple mechanisms for communication to ensure the system is accessible and effective in responding to local needs.

Smit Gade of the Good Business Lab Foundation in India will perform a study in India to better understand the constraints for working mothers in accessing employer-provided childcare and the effects of increasing uptake of this childcare on working mothers and their children. They will perform a randomized controlled trial, recruiting sewing machine operators at a garment factory and unemployed women that will be offered job interviews at the factory. The factory offers free on-site childcare, but uptake is low. The trial arms will test the effect of subsidizing the cost of traveling with children to work, of providing information on the quality of the free creches at the factory, or of both combined. They will determine if the study treatments increase working mothers' uptake of childcare services and encourage unemployed women to interview for work. Trial outcome measures will include assessment of women's quality of life and of their children's welfare.

Anurag Agrawal of Ashoka University in India will develop an LLM-based platform to support medical decision making by home healthcare workers in India who are meeting the growing demand for home-based palliative care. The platform will use an existing proprietary LLM to extract and summarize relevant clinical information, connecting it with an existing open-source AI chatbot to generate advice in a conversational format for healthcare workers. They will test the platform using a dataset they will build of palliative care scenarios, focused initially on care for lung diseases, and they will compare outputs from several different open-source LLMs to guide the platform's final configuration. Expert clinicians will evaluate the clinical advice generated by the platform for its factual accuracy and relevance to the Indian sociocultural context.

Aline Rocha of Fiocruz in Brazil will link datasets through the Center for Data Integration and Knowledge in Health (CIDACS) to measure the impact of extreme climate events on maternal and infant nutritional outcomes across diverse ecological settings and population groups in Brazil. They will integrate longitudinal data from two datasets, the 100 Million Brazilian Cohort and the Climate and Health Data Platform, connecting them through the municipality where mothers reside. The cohort database links data from social protection programs to administrative and health databases to assess the social determinants of health. The data platform extracts and links climate and environmental data from the year 2000 onwards from existing open-source databases. The integration of these two datasets will guide evidence-based programs to enhance the resilience of health services and mitigate the effects of climate change on maternal and child health, particularly for those most vulnerable.

This grant is funded by Grand Challenges Brazil.

Livia Casseb of Evandro Chagas Institute in Brazil will develop models to understand and predict the impact of climate change on the Aedes mosquito-transmitted arboviral diseases dengue, chikungunya, and Zika in Brazil. The models will integrate a variety of existing data for the different geographic regions of Brazil, including historical data on climate, landscape characteristics, population density, mosquito distribution, and public health. They will also incorporate structured and unstructured data from community networks, teaching and research institutions, and state government entities. The models will reveal interdependent relationships and interactions, including spatial correlations between the arboviral diseases over time. They will develop distinct models for individual geographic regions to serve as early warning systems for arboviral disease outbreaks and to guide local interventions.

This grant is funded by Grand Challenges Brazil.

Hernan Argibay of Fiocruz in Brazil will support a participatory research approach for communities in urban slums in Salvador, Brazil to develop and monitor the impact of interventions to reduce the risk of vector-borne and zoonotic diseases. Guided by local needs, new community-led projects will focus on environmentally transmitted diseases (e.g., leptospirosis and enteric infections) and vector-borne diseases (e.g., leishmaniasis, rickettsiosis, and those caused by the arboviruses dengue, chikungunya, and Zika), all of whom could increase in incidence due to climate change. Intervention projects will include environmental clean-up to reduce disease transmission by mosquitos and rats, planting to improve drainage and provide additional food sources, and using an app to map potential risk factors and guide new projects. They will measure intervention impact, including community-led pathogen surveillance using vector traps, water sampling, and metagenomic sequencing.

This grant is funded by Grand Challenges Brazil.

Andréia Santo of the Associação Redes de Desenvolvimento da Maré in Brazil will collect temperature, humidity, and air quality data together with associated health data for residents in the Maré favelas in Rio de Janeiro to better understand the causes of respiratory diseases and reduce their burden. They will also train high school girls as citizen scientists to work alongside health professionals in collecting and analyzing data and developing practical technologies to mitigate the health effects of heat and poor air quality. This participatory science approach will serve as a sustainable mechanism to understand the impacts of climate change on the health of particularly vulnerable communities in Brazil and to guide the development of innovative solutions. In selected residences in Maré, they will pilot an intervention consisting of a bio-concrete wall coating to reduce indoor relative humidity as a cause of heat stress for occupants.

This grant is funded by Grand Challenges Brazil.

Sheetal Silal of the University of Cape Town in South Africa will establish a research consortium to analyze how climate change affects the transmission and control of mosquito-borne diseases, focusing on how to optimize interventions for malaria, chikungunya and dengue in Southern Africa. The consortium will integrate research projects led by local data scientists working closely with local decision-makers. Through mathematical and statistical modeling together with climate science, these projects will determine climate scenarios across time scales relevant for management of mosquito-borne diseases. These time scales will encompass short-term windows (6-12 months) as well as longer windows (5-10 years) relevant for policy planning and that incorporate the predicted impact and costs of new interventions. The consortium will also explore even longer windows (over 30 years) to provide predictions useful to initiate policy discussions and bring attention to the long-term implications of climate change on disease control strategies.

This grant is funded by The Wellcome Trust.

Corine Ngufor of the Centre de Recherche Entomologique de Cotonou in Benin will evaluate insecticide-based strategies that can complement insecticide-treated bed nets for improved malaria control. In the laboratory, they will test the killing ability of combinations of insecticides, using pyrethroid-susceptible as well as pyrethroid-resistant laboratory-maintained mosquitoes. In experimental hut trials, they will test different strategies, including a combination of a spatial repellent (a transfluthrin passive emanator) with dual active-ingredient bed nets that are two years into their three-year product lifespan. They will also use hut trials with controlled release of insecticide-susceptible and -resistant mosquitoes to determine how different strategies are affected by resistance and by environmental factors such as temperature and humidity. Data modeling will be performed to assess the relative importance of different variables, helping identify the most effective insecticide-based strategies to accomplish malaria control goals.

Roman Thibeaux of the Institut Pasteur de Nouvelle Calédonie in New Caledonia will examine how climate-driven soil changes and societal and behavioral factors can affect the incidence of leptospirosis to develop community-centered prevention strategies. The causal agent of the disease is the bacterium Leptospira, which can be found in water or soil contaminated with the urine of infected animals and thus can spread following heavy rainfall. Leptospirosis is endemic in the New Caledonia archipelago in the South Pacific, with potential climate-driven increases in incidence. Using soil microcosms in the laboratory, they will explore the effects of temperature, rainfall, and soil structure on Leptospira survival and dispersion. Through interviews and focus groups with New Caledonia community members together with ethnographic fieldwork, they will record local perceptions and knowledge relevant to leptospirosis and its transmission. In partnership with local community members and health authorities, they will then identify sustainable strategies to reduce leptospirosis incidence.

This grant is funded by the Pasteur Network.

Bryan Ranger of Boston College in the U.S. will develop a cost-effective, portable, and automated ultrasound tool to monitor nutritional health of young pregnant women in Ethiopia. The tool will incorporate AI models that guide users in collecting high quality data, so the tool can be used by frontline and community healthcare workers without extensive ultrasound training, and the models will use this data to predict metrics of nutritional status. In a pilot study conducted at the Jimma Medical center, they will create a database of ultrasound scans, anthropometry, body composition measured by gold standard techniques, and the associated clinical data from a group of young pregnant women. Ultrasound measurements will incorporate data on user position to identify the most informative positions via machine learning. They will survey clinical users to guide the ultimate design of the ultrasound system.

Susan Rumisha of Ifakara Health Institute in Tanzania will support the establishment of data modeling hubs in the Democratic Republic of Congo, Nigeria, and Tanzania, linking them into a collaborative network to guide the control of mosquito-borne diseases in the face of climate change. The focus will be on the direct and indirect effects of environmental change on malaria, modeling the interplay of these effects with public health systems and mosquito vector and disease patterns. This will encompass modeling mosquito vector distribution, abundance, and seasonality using historical climate data together with new microclimate information. The models will be designed to support national programs in prioritizing vector surveillance activities, targeting interventions, and developing early warning systems for emerging health threats. The network will strengthen model-building expertise and could be adapted to address mosquito-borne arboviral diseases.

This grant is funded by The Wellcome Trust.

Bernard Bett of the International Livestock Research Institute in Kenya will develop disease transmission models for two Aedes mosquito-borne arboviral diseases, dengue and chikungunya, and use the models to design decision support tools to guide surveillance and control of these diseases in Kenya, Somalia and Ethiopia. The models will be validated with longitudinal field data, including mosquito population density, infection patterns, blood meal sources, and the incidence of Aedes-borne diseases in humans. The models will be used to estimate important metrics for disease management, such as time-to-disease outbreak, cost effectiveness of control, and spatial distribution of risk. They will also help identify how the ecological tipping points for outbreaks of dengue and chikungunya compare to each other and how existing control measures for the two diseases could be integrated for better health outcomes. The project will link institutions including the Ethiopia Public Health Institute, Kenya’s Department of Disease Surveillance and Epidemic Response, Somalia’s Federal Ministry of Health, Jomo Kenyatta University of Agriculture and Technology, Abrar University, the Kenya Medical Research Institute, Ohio State University, Global One Health Initiative, and the International Livestock Research Institute.

This grant is funded by The Wellcome Trust.

James Beeson of Burnet Institute in Australia, Melissa Kapulu of Health Research Operations Kenya Limited in Kenya, Isaac Ssewanyana of Infectious Diseases Research Collaboration in Uganda, Faith Osier of Imperial College London in the U.K. and Pras Jagannathan of Stanford University in the U.S., will analyze clinical samples using an antibody functional assay platform with malaria antigen arrays to identify antigens targeted by protective antibodies for next-generation malaria vaccines. They will identify antigen-specific functional antibodies that strongly correlate with protective immunity to malaria observed in clinical studies with two populations: Kenyan adults after controlled experimental challenge infection with Plasmodium falciparum and children followed longitudinally who were naturally exposed in Uganda and in Papua New Guinea. They will then use biostatistical modeling approaches to identify antigen and functional antibody types that most frequently occur in protective combinations, identifying additive and synergistic combinations of responses and responses most predictive of protective immunity across age groups and populations. This will enable prioritization of antigens and their combinations for malaria vaccine candidates.

Rajshekhar Karpoormath of the University of KwaZulu-Natal in South Africa will test a set of potential anti-TB hit compounds against clinically relevant TB strains, using the results to generate optimized hit compounds for development of new anti-TB drugs. They will screen the potential hits against susceptible, monodrug-resistant, multidrug-resistant, and extensively drug-resistant TB strains as well as other Mycobacterium strains. The screening results will inform structure-based drug design to generate optimized hit compounds. Potential lead hits will be screened again, with the most promising evaluated against intracellular bacteria in macrophages, tested for in vitro cytotoxicity, and evaluated for mechanism of action in bioassays including carbon-isotope tracing metabolomics and an in vitro granuloma assay.

Solomon Hailemeskel of Debre Berhan University in Ethiopia will pilot test midwife-led birthing centers for pregnant women and newborns at low risk of complications to increase access to safe, high-quality childbirth experiences for Ethiopian women. They will implement a multicenter randomized controlled trial, recruiting a cohort of pregnant women from antenatal care clinics across diverse healthcare facilities to ensure a representative sample. After training midwives to provide continuity of care before, during, and after pregnancy, they will establish midwife-led birthing centers in dedicated spaces, either within or separate from a higher-level health facility. A subset of trial participants will be randomly assigned to the birthing centers. They will compare outcomes for the two groups, including data on maternal and neonatal health outcomes, as well as qualitative data from interviews of mothers, midwives, and healthcare providers.

Rapidemic in the Netherlands will collaborate with Mohammed Majam of Ezintsha in South Africa to develop a prototype for a molecular test for rapid multiplex diagnosis of chlamydia and gonorrhea, while determining the requirements for its deployment in South African primary care settings to serve hard-to-reach populations. The test system will be designed to diagnose symptomatic and asymptomatic patients accurately and inexpensively using a rapid and disposable test. To guide prototyping, they will research user preferences and assess the usability of the developed device. They will also conduct research to ensure that the development meets regulatory requirements for the South African market and addresses the needs of pharmacies and primary healthcare settings in South Africa.

Sona Shah of Neopenda, PBC in Kenya will integrate ChatGPT-4 as a virtual assistant for the wearable, vital sign monitor neoGuard, supporting healthcare providers in effectively monitoring and managing neonatal health. They will train ChatGPT-4 to help providers identify and address challenges with the neoGuard monitor, such as poor sensor placement on the patient, and to give providers appropriate recommendations based on vital sign data together with the clinical information they gathered. This real-time clinical decision support would be particularly beneficial in remote and understaffed healthcare facilities. For model training, they will use a dataset of newborns admitted to a hospital in Kenya, including vital signs, clinical histories, and treatment outcomes, as well as insights from unstructured clinical notes extracted using natural language processing. They will evaluate use of neoGuard with ChatGPT-4 for reliability, accuracy, and user-friendliness, and compare neonatal patient outcomes before and after ChatGPT-4 integration with the monitor.

Moses Obimbo Madadi of the University of Nairobi in Kenya and Aida Sivro of the University of Manitoba in Canada will determine the molecular epidemiology of human papillomavirus (HPV) in cervical cancer cases in Kenya to enable monitoring of changes in the prevalence of HPV types targeted by current vaccines and detect possible replacement with other types. They will perform a cross-sectional study on Kenyan women being followed-up for cervical cell abnormalities at hospitals in Nairobi and in rural Kenya. Outcome measures will include prevalence of HPV genotypes by age, geographic location, and HIV status. HPV genotypes will be stratified by cervical diagnosis to determine the top genotypes associated with cervical cancer. This research will provide robust and standardized statistics on the burden and genetics of oncogenic HPV infection in Kenyan women.